TY - JOUR
KW - Humans
KW - *Diabetes Mellitus, Type 2/complications/drug therapy/epidemiology
KW - Cohort Studies
KW - Cross-Sectional Studies
KW - *Renal Insufficiency, Chronic/epidemiology
KW - England/epidemiology
KW - *Heart Failure
KW - Adult nephrology
KW - Diabetes & endocrinology
KW - Diabetic nephropathy & vascular disease
KW - epidemiology
AU - S. Cook
AU - N. Schmedt
AU - J. Broughton
AU - P. Kalra
AU - L. Tomlinson
AU - J. Quint
AD - National Heart and Lung Institute, Imperial College London, London, UK sarah.cook@imperial.ac.uk.
Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Bayer AG, Berlin, Germany.
Bayer plc, Reading, UK.
Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.
Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
National Heart and Lung Institute, Imperial College London, London, UK.
AN - 36882249
BT - BMJ Open
C2 - PMC10008473
DO - 10.1136/bmjopen-2022-065927
DP - NLM
ET - 2023/03/08
LA - eng
M1 - 3
N1 - 2044-6055
Cook, Sarah
Schmedt, Niklas
Broughton, Julie
Kalra, Philip A
Tomlinson, Laurie A
Orcid: 0000-0001-8848-9493
Quint, Jennifer K
Orcid: 0000-0003-0149-4869
Journal Article
Research Support, Non-U.S. Gov't
England
BMJ Open. 2023 Mar 7;13(3):e065927. doi: 10.1136/bmjopen-2022-065927.
PY - 2023
SN - 2044-6055
EP - e065927
T2 - BMJ Open
TI - Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink
VL - 13
ER -